Menu Search
Equities

LifeTech Scientific Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
81X:FRA

LifeTech Scientific Corp

Actions
  • Price (EUR)0.169
  • Today's Change-0.002 / -1.17%
  • Shares traded1.18k
  • 1 Year change+17.36%
  • Beta0.8635
Data delayed at least 15 minutes, as of Feb 06 2026 09:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

LifeTech Scientific Corp is an investment holding company primarily engaged in the development, manufacture and trading of interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company mainly operates its business through three segments. The Structural Heart Diseases Business segment is engaged in trading, manufacture, research and development of devices related to structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in trading, manufacture, research and development of devices related to peripheral vascular diseases. The Cardiac Pacing and Electrophysiology Business segment is engaged in trading, manufacture, research and development of devices related to cardiac pacing and electrophysiology. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)1.49bn
  • Net income in HKD80.92m
  • Incorporated2006
  • Employees1.27k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.